RDM1P3

Across TCGA pan-cancer cohorts, RDM1P3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RDM1P3 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RDM1P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RDM1P3 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LAML show a favorable association.

SKCM, LAML, and LUSC are the cancer types where RDM1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Quartile	All	0.876	0.727	.001	61	view →
LAML	DFS	Tertile	All	0.554	0.221	.002	32	view →
LUSC	DFS	Tertile	III,IV	0.506	0.785	.008	19	view →
UCS	DFS	Tertile	IV	0.975	0.419	.024	18	view →
BRCA	DFS	Quartile	III,IV	0.943	0.780	.006	18	view →
COAD	DFS	Tertile	All	0.495	0.774	.003	17	view →
LUAD	OS	Tertile	III,IV	0.769	0.598	.015	16	view →
READ	DFS	Median	IV	0.356	0.845	.001	15	view →
UCEC	DFS	Tertile	All	0.480	0.772	.026	14	view →
ACC	DFS	Quartile	All	0.661	0.208	.028	12	view →
KIRC	DFS	Tertile	II,III,IV	0.411	0.600	.011	10	view →
MESO	DFS	Quartile	III,IV	0.354	0.576	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RDM1P3–SKCM (OS)

Open the SKCM breakdown →